Chiron Real Estate (XRN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Portfolio occupancy at quarter-end was 96.1% with a weighted average lease term of 5.6 years and average rent coverage ratio of 4.6x.
Net income attributable to common shareholders was $1.8 million ($0.03/share), down from $3.1 million ($0.05/share) year-over-year.
FFO and AFFO per share/unit declined year-over-year, primarily due to cash-basis tenants and lower occupancy.
Completed the first tranche of a 15-property acquisition for $80.3 million and closed the remainder post-quarter; under contract for a $70 million, five-property portfolio at a 9% cap rate, expected to close in 2025.
Re-leased Beaumont facility to CHRISTUS Health after Steward's bankruptcy, securing a new 15-year triple net lease.
Financial highlights
Total revenues for Q3 2024 were $34.3 million, down 3.5% year-over-year, mainly due to lower occupancy and cash-basis tenants.
Total expenses were $32.7 million, slightly down from $33 million year-over-year, with reduced depreciation offset by higher operating and interest expenses.
FFO was $13.7 million ($0.19/share and unit), down from $15.3 million ($0.22/share and unit) year-over-year.
AFFO was $15.3 million ($0.22/share and unit), compared to $16.5 million ($0.23/share and unit) in Q3 2023.
Three property dispositions in 2024 generated $20.2 million in gross proceeds, resulting in a net loss of $1.6 million.
Outlook and guidance
Projected full-year 2024 capital expenditures of $12–$14 million.
Expect rent from CHRISTUS lease to commence in March or April 2025.
Management expects to complete the $69.6 million five-property acquisition in two tranches during the first half of 2025, subject to customary conditions.
Optimistic about occupancy and leasing activity for 2025, with an 85% retention rate trending for 2024 expirations.
Management anticipates continued pressure from elevated interest rates and healthcare wage inflation, but expects demographic trends and outpatient care shifts to support long-term demand.
Latest events from Chiron Real Estate
- Portfolio shift to higher-return senior housing assets and JV unlocks $200M for reinvestment.XRN
Corporate presentation6 Jul 2026 - Q3 2025 net loss from impairment, but FFO/AFFO and rental revenue grew year-over-year.XRN
Q3 202530 Jun 2026 - AFFO and FFO rose, occupancy remained high, and dividend was cut to support growth and stability.XRN
Q2 202530 Jun 2026 - AFFO guidance reaffirmed as net income rises and portfolio expands despite tenant bankruptcy.XRN
Q1 202530 Jun 2026 - Q2 net loss from property sale, but AFFO, occupancy, and acquisition activity remain strong.XRN
Q2 202430 Jun 2026 - Strong Q4 results and stable AFFO, with acquisitions and JV supporting 2025 growth.XRN
Q4 202430 Jun 2026 - Healthcare REIT registers Series C Preferred and Common Stock for resale by major investors.XRN
Registration filing16 Jun 2026 - $425M in senior housing acquisitions, $100M equity, and 36% dividend cut drive growth.XRN
Q1 202613 May 2026 - Strategic acquisitions and a diversified portfolio drive growth and support a well-covered dividend.XRN
Investor presentation7 May 2026